Merck (MRK) is a publicly traded Healthcare sector company. As of May 20, 2026, MRK trades at $114.00 with a market cap of $278.00B and a P/E ratio of 31.77. MRK moved -1.07% today. Year to date, MRK is +5.17%; over the trailing twelve months it is +44.93%. Its 52-week range spans $73.31 to $125.14. Analyst consensus is buy with an average price target of $135.61. Rallies surfaces MRK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading MRK stock inside the company?
Recent MRK insider activity includes Guindo Chirfi sold 10.00K, Li Dean Y sold 10.23K, Guindo Chirfi sold 10.00K, Zachary Jennifer sold 25.95K, and Zachary Jennifer sold 56.79K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
MRK Key Metrics
Key financial metrics for MRK
Metric
Value
Price
$114.00
Market Cap
$278.00B
P/E Ratio
31.77
EPS
$3.57
Dividend Yield
0.85%
52-Week High
$125.14
52-Week Low
$73.31
Volume
5.25M
Avg Volume
0
Revenue (TTM)
$65.77B
Net Income
$8.93B
Gross Margin
73.91%
Recent MRK Insider Trades
Guindo Chirfi sold 10.00K (~$1.21M) on Feb 12, 2026.
Li Dean Y sold 10.23K (~$1.20M) on Feb 10, 2026.
Guindo Chirfi sold 10.00K (~$1.18M) on Feb 9, 2026.
Zachary Jennifer sold 25.95K (~$3.09M) on Feb 9, 2026.
Zachary Jennifer sold 56.79K (~$6.77M) on Feb 9, 2026.
Recent MRK insider activity includes Guindo Chirfi sold 10.00K, Li Dean Y sold 10.23K, Guindo Chirfi sold 10.00K, Zachary Jennifer sold 25.95K, and Zachary Jennifer sold 56.79K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for MRK?
Yes. Rallies tracks MRK insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is MRK research on Rallies investment advice?
No. Rallies provides research, data, and educational context for MRK. It does not provide personalized investment advice.
